About half of mental health facilities and one-third of substance use treatment facilities reported having smoke-free campuses in 2016, according to a new report from the Centers for Disease Control and Prevention and Substance Abuse and Mental Health Services Administration. Nearly half of mental health facilities and two-thirds of substance use treatment facilities screened patients for tobacco use, but fewer offered counseling or other therapies to quit, based on survey data. “Several actions could help address actual and perceived barriers to integrating tobacco dependence treatment into behavioral health treatment,” the authors said. “These actions could include removing administrative and financial barriers to delivery of cessation interventions and integrating tobacco screening and treatment protocols into facilities’ workflows and electronic health record systems.” People with mental or substance use disorders are more than twice as likely to smoke as those without, and are more likely to die from a smoking-related illness than from a behavioral health condition, the report notes.

Headline
There are now 17,180 confirmed cases of cyclosporiasis in the U.S., the Centers for Disease Control and Prevention reported Aug. 25. At least 11,844 additional…
Headline
The Food and Drug Administration has approved a blood test for detecting Alzheimer’s by Roche and Eli Lilly, according to an announcement Aug. 24 by Roche. The…
Headline
There have been 15,716 confirmed cases of cyclosporiasis across 47 states, Washington, D.C., and Puerto Rico since May 1, the Centers for Disease Control and…
Blog
By Rani E. Snyder, President, The John A. Hartford Foundation and Dr. Chris DeRienzo, AHA Chief Physician Executive/President of AHA’s HRET As the U.S.…
Headline
The Department of Health and Human Services Aug. 14 announced that three health systems have signed the agency’s voluntary pledge related to hospital efforts…
Headline
The Centers for Disease Control and Prevention Aug. 11 released a health advisory on the risk of severe arboviral disease among patients receiving B-cell-…